1 asset in GM2 Gangliosidosis
Therapeutic assets addressing GM2 Gangliosidosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
az-3102 GM2 Gangliosidosis | Azafaros B.V. | P3 | NR () |
Therapeutic assets addressing GM2 Gangliosidosis, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
az-3102 GM2 Gangliosidosis | Azafaros B.V. | P3 | NR () |